Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caplyta in Social Anxiety Disorder
NCT07799493Phase 4Recruiting
- Start
- Sep 2026
- Primary completion
- May 2028
- Countries
- 1
01
Overview
A Phase 4 trial of lumateperone in Social Anxiety Disorder (SAD). Started Sep 2026; status: recruiting.
02
Drugs
lumateperone
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT07799493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07799493.